Product correctly added to cart.

discount label
DL-Homocystine-3,3,3’,3’,4,4,4’,4’-d8
View 3D

TRC logo

DL-Homocystine-3,3,3’,3’,4,4,4’,4’-d8

CAS: 108641-82-3

Ref. TR-H591292

25mg
367.00 €
250mg
2,528.00 €
Estimated delivery in United States, on Tuesday 12 Nov 2024

Product Information

Name:
DL-Homocystine-3,3,3’,3’,4,4,4’,4’-d8
Controlled Product
Synonyms:
  • 2-amino-4-[(3-amino-3-carboxy-1,1,2,2-tetradeuteriopropyl)disulfanyl]-3,3,4,4-tetradeuteriobutanoic acid
  • Dl-Homocystine-3,3,3',4,4,4',4-D8
Description:

Applications Labelled DL-Homocystine is used in the synthesis of potential antitumor agents through inhibition of L-asparagine. There is growing clinical evidence that elevated homocysteine levels are associated with an increased risk of venous and arterial thrombosis.
References Brynes, S. et al.: J. Pharm. Sci., 67, 1550 (1978); Lauricella, A. et al.: Thromb. Res., 107, 75 (2002);

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
TRC
Long term storage:
Notes:

Chemical properties

Molecular weight:
276.40
Formula:
C8H8H8N2O4S2
Color/Form:
Neat
InChI:
InChI=1S/C8H16N2O4S2/c9-5(7(11)12)1-3-15-16-4-2-6(10)8(13)14/h5-6H,1-4,9-10H2,(H,11,12)(H,13,14)/i1D2,2D2,3D2,4D2
InChI key:
InChIKey=ZTVZLYBCZNMWCF-CRSNXTHKSA-N
SMILES:
[2H]C([2H])(SSC([2H])([2H])C([2H])([2H])[C@H](N)C(=O)O)C([2H])([2H])[C@H](N)C(=O)O
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TR-H591292 DL-Homocystine-3,3,3’,3’,4,4,4’,4’-d8

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".